Egypt will soon receive two new coronavirus drugs that
received the approval of the US Food and Drug Administration, for use at the
beginning of infection with the virus, the spokesperson for the Ministry of
Health Hossam Abdel Ghaffar announced.
It includes a drug that the patient receives intramuscularly to prevent moderate and severe symptoms of the coronavirus, he explained.
Abdel Ghaffar explained that from January 21 to 27, Egypt will receive enough doses of the drug to cover 50,000 patients. It will be given to people with coronavirus who have chronic diseases, and it will be taken by injection at the hospitals of the Ministry of Health and university hospitals, he said.
One of the drugs, Merck, is taken orally, and four Egyptian companies have applied to manufacture it locally. It will be available in hospitals within three weeks, according to Abdel Ghaffar.
Regarding drug experiments on patients, Abdel Ghaffar explained that there is a law issued for clinical research which regulates drug experiments as the process must be subject to a set of conditions.
Source: Egypt Today
